“Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma With GEMCAP and MFOLFIRINOX Regimens: Adverse Events and Long-Term Outcomes”. Voprosy Onkologii, vol. 72, no. 1, Mar. 2026, p. OF-2421, https://doi.org/10.37469/0507-3758-2026-72-1-OF-2421.